Viewing data from:

ISRADIPINE

ANDA

ISRADIPINE | A077317 | WATSON LABORATORIES INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC

2 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 2 NDCs

Highest NADAC/Unit

$1.65

per ea

Lowest NADAC/Unit

$1.50

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
16252054001ISRADIPINE 5 MG CAPSULE	$1.65	EA	Generic	—	2026-06-17
16252053901ISRADIPINE 2.5 MG CAPSULE	$1.50	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain5 active DMFs3 inactive

5 active API suppliers hold Drug Master Files for this ingredient.

SOLARA ACTIVE PHARMA SCIENCES LTDISRADIPINE, USP

DMF 163692003

STERLING WISCONSIN LLCISRADIPINE (FP-043)

DMF 168122003

QUIMICA SINTETICA SAISRADIPINE

DMF 173672004

YANGZHOU PHARMACEUTICAL CO LTDISRADIPINE (USP26)

DMF 173842004

CHEMOSWED ABISRADIPINE

DMF 193762006

SUN PHARMACEUTICAL INDUSTRIES LTDInactiveISRADIPINE UPS

DMF 178732004

CHEMWERTH INCInactiveISRADIPINE USP, NON-STERILE BULK DRUG SUBSTANCE

DMF 207492007

SAI ADVANTIUM PHARMA LTDInactiveIsradipine USP

DMF 210132007

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — 2.5MG

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Jan 5, 2006

No patent or exclusivity listings for this strength.

#002 — 5MG

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Jan 5, 2006